Immune response to anti-SARS-CoV-2 prime-vaccination in patients with cancer: a systematic review and meta-analysis.

MLA

Martins-Branco, Diogo, et al. “Immune Response to Anti-SARS-CoV-2 Prime-Vaccination in Patients with Cancer: A Systematic Review and Meta-Analysis.” Journal of Cancer Research and Clinical Oncology, vol. 149, no. 7, July 2023, pp. 3075–80. EBSCOhost, https://doi.org/10.1007/s00432-022-04185-w.

APA

Martins-Branco, D., Nader-Marta, G., Tecic Vuger, A., Debien, V., Ameye, L., Brandão, M., Punie, K., Loizidou, A., Willard-Gallo, K., Spilleboudt, C., Awada, A., Piccart, M., & de Azambuja, E. (2023). Immune response to anti-SARS-CoV-2 prime-vaccination in patients with cancer: a systematic review and meta-analysis. Journal of Cancer Research and Clinical Oncology, 149(7), 3075–3080. https://doi.org/10.1007/s00432-022-04185-w

Chicago

Martins-Branco, Diogo, Guilherme Nader-Marta, Ana Tecic Vuger, Veronique Debien, Lieveke Ameye, Mariana Brandão, Kevin Punie, et al. 2023. “Immune Response to Anti-SARS-CoV-2 Prime-Vaccination in Patients with Cancer: A Systematic Review and Meta-Analysis.” Journal of Cancer Research and Clinical Oncology 149 (7): 3075–80. doi:10.1007/s00432-022-04185-w.